Saltzman Edward C 4
4 · Nurix Therapeutics, Inc. · Filed Sep 14, 2022
Insider Transaction Report
Form 4
Saltzman Edward C
Director
Transactions
- Award
Director Stock Option (right to buy)
2022-09-12+50,000→ 50,000 totalExercise: $16.29Exp: 2032-09-11→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/36 of the total shares monthly beginning October 12, 2022 until the option is fully vested on September 12, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date.